| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VTYX | Ventyx Biosciences, Inc. | Gujrathi Sheila | Director | Mar 30, 2023 | Option Exercise | $6.03 | 100,000 | 603,000 | 100,000 | Mar 31, 2023, 04:46 PM | |
| VTYX | Ventyx Biosciences, Inc. | Gujrathi Sheila | Director | Mar 30, 2023 | Sale | $33.73 | 100,000 | 3,373,240 | 0 | Mar 31, 2023, 04:46 PM | |
| GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Sep 27, 2019 | Buy | $16.80 | 10,000 | 167,980 | 4,048,242 | Sep 27, 2019, 10:39 AM | |
| RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Officer | Nov 11, 2014 | Sale | $108.99 | 30,000 | 3,269,700 | 120,661 | Nov 12, 2014, 08:35 PM | |
| RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Officer | Sep 22, 2014 | Sale | $61.45 | 30,000 | 1,843,500 | 150,661 | Sep 24, 2014, 09:00 PM | |
| RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Officer | May 14, 2013 | Option Exercise | $5.25 | 13,333 | 69,998 | 180,661 | May 14, 2013, 05:31 PM |
Menu